- Report
- May 2023
- 160 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- April 2023
- 160 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- April 2023
- 147 Pages
Global
From €5960EUR$5,999USD£4,955GBP
- Report
- April 2023
- 140 Pages
Global
From €4421EUR$4,450USD£3,676GBP
- Report
- October 2023
- 145 Pages
Global
From €3129EUR$3,150USD£2,602GBP
- Report
- March 2020
- 49 Pages
Global
€1309EUR$1,318USD£1,089GBP
- Report
- April 2023
- 120 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- April 2023
- 120 Pages
Global
From €4719EUR$4,750USD£3,924GBP
- Report
- May 2023
- 87 Pages
Global
From €3472EUR$3,495USD£2,887GBP
- Report
- May 2023
- 71 Pages
Global
From €3472EUR$3,495USD£2,887GBP
- Report
- February 2023
- 48 Pages
Global
From €3969EUR$3,995USD£3,300GBP
- Drug Pipelines
- May 2022
- 138 Pages
Global
From €10923EUR$10,995USD£9,082GBP
- Report
- April 2022
- 53 Pages
Global
From €3472EUR$3,495USD£2,887GBP
- Report
- March 2022
- 45 Pages
Global
From €3472EUR$3,495USD£2,887GBP
- Drug Pipelines
- January 2022
- 84 Pages
Global
From €6949EUR$6,995USD£5,778GBP
- Clinical Trials
- November 2021
- 420 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Clinical Trials
- September 2021
- 102 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Drug Pipelines
- September 2018
- 36 Pages
Global
From €2484EUR$2,500USD£2,065GBP
- Report
- September 2023
- 169 Pages
Global
From €2781EUR$2,799USD£2,312GBP
- Report
- August 2022
United States
From €1927EUR$1,940USD£1,602GBP
The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more